| Product NDC: | 49527-886 |
| Proprietary Name: | CLINIQUE |
| Non Proprietary Name: | octinoxate, octisalate, avobenzone, and oxybenzone |
| Active Ingredient(s): | 3; 7.4; 5; 2 mL/100mL; mL/100mL; mL/100mL; mL/100mL & nbsp; octinoxate, octisalate, avobenzone, and oxybenzone |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | LOTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 49527-886 |
| Labeler Name: | CLINIQUE LABORATORIES INC. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20040901 |
| Package NDC: | 49527-886-01 |
| Package Description: | 1 BOTTLE in 1 CARTON (49527-886-01) > 100 mL in 1 BOTTLE |
| NDC Code | 49527-886-01 |
| Proprietary Name | CLINIQUE |
| Package Description | 1 BOTTLE in 1 CARTON (49527-886-01) > 100 mL in 1 BOTTLE |
| Product NDC | 49527-886 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | octinoxate, octisalate, avobenzone, and oxybenzone |
| Dosage Form Name | LOTION |
| Route Name | TOPICAL |
| Start Marketing Date | 20040901 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | CLINIQUE LABORATORIES INC. |
| Substance Name | AVOBENZONE; OCTINOXATE; OCTISALATE; OXYBENZONE |
| Strength Number | 3; 7.4; 5; 2 |
| Strength Unit | mL/100mL; mL/100mL; mL/100mL; mL/100mL |
| Pharmaceutical Classes |